Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basil S Lewis

Showing results (161-170 of 240) with videos related to

Pageof 24
Sort By:
European Heart Journal|July 19, 2021
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapyVictor Aboyans, Rupert Bauersachs, Lucia Mazzolai, et al.
Lancet (London, England)|August 31, 2012
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trialBenjamin M Scirica, Marc P Bonaca, Eugene Braunwald, et al.
American Heart Journal|February 16, 2018
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trialMatthew W Sherwood, Renato D Lopes, Jie Lena Sun, et al.
Lancet (London, England)|January 19, 2010
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind studyChristopher P Cannon, Robert A Harrington, Stefan James, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trialJustin A Ezekowitz, Basil S Lewis, Renato D Lopes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesionsRicardo A Costa, J Eduardo Sousa, Alexandre Abizaid, et al.
Circulation|November 15, 2017
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)Marc P Bonaca, Patrice Nault, Robert P Giugliano, et al.
European Heart Journal|December 26, 2015
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on ThrombosisAlexander Niessner, Juan Tamargo, João Morais, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditisPaul C Cremer, David Lin, Sushil A Luis, et al.
American Heart Journal|February 16, 2018
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trialDavid Kopin, W Schuyler Jones, Matthew W Sherwood, et al.
Pageof 24

Showing results (161-170 of 240) with videos related to

Sort By:
Pageof 24
European Heart Journal|July 19, 2021
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapyVictor Aboyans, Rupert Bauersachs, Lucia Mazzolai, et al.
Lancet (London, England)|August 31, 2012
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trialBenjamin M Scirica, Marc P Bonaca, Eugene Braunwald, et al.
American Heart Journal|February 16, 2018
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trialMatthew W Sherwood, Renato D Lopes, Jie Lena Sun, et al.
Lancet (London, England)|January 19, 2010
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind studyChristopher P Cannon, Robert A Harrington, Stefan James, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trialJustin A Ezekowitz, Basil S Lewis, Renato D Lopes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesionsRicardo A Costa, J Eduardo Sousa, Alexandre Abizaid, et al.
Circulation|November 15, 2017
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)Marc P Bonaca, Patrice Nault, Robert P Giugliano, et al.
European Heart Journal|December 26, 2015
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on ThrombosisAlexander Niessner, Juan Tamargo, João Morais, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditisPaul C Cremer, David Lin, Sushil A Luis, et al.
American Heart Journal|February 16, 2018
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trialDavid Kopin, W Schuyler Jones, Matthew W Sherwood, et al.
Pageof 24